Your browser doesn't support javascript.
loading
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies.
Wang, Jie; Li, Chen; He, Kaijie; Kuang, Zhihui; Lu, Jia; Yao, Ying; He, Fufan; Li, Ninghuan; Li, Li; Fu, Fenggen; Wu, Zhihai; Zhou, Shuaixiang; Kang, Dian; Qiu, Xuan; Wu, Min; Liu, Yang; Cao, Xiaochao; Xu, Mengqiu; Chen, Bingliang; Wu, Weiwei; Guo, Feng.
Affiliation
  • Wang J; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Li C; Department of Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, China.
  • He K; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Kuang Z; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Lu J; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Yao Y; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • He F; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Li N; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Li L; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Fu F; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Wu Z; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Zhou S; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Kang D; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Qiu X; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Wu M; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Liu Y; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
  • Cao X; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Xu M; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
  • Chen B; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Wu W; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China.
  • Guo F; Innovent Biologics (Suzhou) Co., Suzhou, Jiangsu, China. bingliang.chen@innoventbio.com.
Cancer Immunol Immunother ; 72(2): 493-507, 2023 Feb.
Article in En | MEDLINE | ID: mdl-35963895
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Year: 2023 Document type: Article